Fig. 4From: Pharmacokinetic modeling of [18F]fluorodeoxyglucose (FDG) for premature infants, and newborns through 5-year-olds a–e The relationship between the patient body weight and percent injected activity in each source organ for newborns (red) and 1- to 5-year-olds (blue). Each data point corresponds to an individual patientBack to article page